We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Optibrium and Certara Collaborate

Collaboration will see integration of Optibrium’s StarDrop and Certera’s D360 platform.
News

Flagship Biosciences Customizes Assay Development and Tissue Image Analysis

Flagship Biosciences and ACD collaborate to develop quantitative RNAscope® assays for pharmaceutical clinical trials in the CLIA environment.
News

Aprea Presents Preliminary Clinical Phase Ib/II Results in Ovarian Cancer at AACR

Company presents results with APR-246 - a novel candidate drug that restores mutant p53 protein into its wild-type function.
News

Drugs that Activate Brain Stem Cells May Reverse Multiple Sclerosis

NIH-funded study identifies over-the-counter compounds that may replace damaged cells.
News

Horizon Discovery & Thermo Agreement

Horizon Discovery Group plc and Thermo Fisher Scientific sign supply and commercialization agreement, which will see Thermo market and distribute Horizon’s X-MAN cell line collection.
News

Long Term Clinical Data from PISCES Stroke Trial

Long term data continue to show good safety profile and evidence of sustained improvements in neurological status and limb function.
News

Sartorius Stedim Biotech Acquires BioOutsource

Aquisition will enable Sartorius to offer increased support to their biopharma clients.
News

Could Maple Syrup Help Cut Use Of Antibiotics?

Syrup extract found to make antibiotics more effective against bacteria.
News

MRC Technology Appoints Finance Director

MRC Technology, an independent life science medical research charity, has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim Finance Director in August 2014.
News

Isarna Initiates First-in-Human Phase I Trial for ISTH0036

Phase I trial designed to evaluate the safety and long-term tolerability of ISTH0036 in patients with advanced glaucoma.
Advertisement